AKR1C3 and prostate carcinoma: In a previous study, we demonstrated that prostate cancer cells become enzalutamide-resistant upon spheroid co-culture with CAFs, associated with increased production of pro-inflammatory cytokines and elevation of steroid biosynthesis with significant upregulation of AKR1C3 in particular [23].